15
Participants
Start Date
March 8, 2021
Primary Completion Date
October 28, 2024
Study Completion Date
October 28, 2024
CIN-107 2 mg dosing
One tablet of CIN-107 2 mg tablets, once daily, by mouth, for dosing at 2 mg.
CIN-107 4 mg dosing
Two tablets of CIN-107 2 mg tablets, once daily, by mouth, for dosing at 4 mg.
CIN-107 8 mg dosing
Four tablets of CIN-107 2 mg tablets, once daily, by mouth, for dosing at 8 mg.
Research Site, Baltimore
Research Site, Columbus
Research Site, Cincinnati
Research Site, Ann Arbor
Research Site, Rochester
Research Site, Chicago
Research Site, West Hollywood
Research Site, San Francisco
Research Site, Greenbrae
Research Site, Dallas
Lead Sponsor
AstraZeneca
INDUSTRY